Bioxcel Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Bioxcel Therapeutics by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $0 | 88 | 0.00 |
2024-06-30 | $0 | 137 | 0.00 |
2024-03-31 | $41k | 15k | 2.79 |
2023-12-31 | $82k | 28k | 2.95 |
2023-09-30 | $18k | 7.7k | 2.41 |
2023-06-30 | $671k | 101k | 6.66 |
2023-03-31 | $1.0M | 56k | 18.65 |
2022-12-31 | $111k | 5.1k | 21.61 |
2022-09-30 | $10k | 811 | 12.33 |
2022-06-30 | $33k | 2.4k | 13.53 |
2022-03-31 | $61k | 2.9k | 21.11 |
2021-12-31 | $426k | 21k | 20.35 |
2021-09-30 | $314k | 10k | 30.36 |
2021-06-30 | $172k | 5.9k | 29.14 |
2020-12-31 | $22k | 480 | 45.83 |
2020-09-30 | $1.2M | 29k | 43.34 |
2020-06-30 | $32k | 600 | 53.33 |
2019-12-31 | $101k | 6.9k | 14.56 |
2019-09-30 | $21k | 3.0k | 7.07 |
2019-06-30 | $43k | 3.9k | 11.07 |
2018-03-31 | $6.3M | 618k | 10.24 |